[HTML][HTML] Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review

MS Mulani, EE Kamble, SN Kumkar… - Frontiers in …, 2019 - frontiersin.org
The acronym ESKAPE includes six nosocomial pathogens that exhibit multidrug resistance
and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae …

[HTML][HTML] Current treatment strategies against multidrug-resistant bacteria: a review

A Parmanik, S Das, B Kar, A Bose, GR Dwivedi… - Current …, 2022 - Springer
There are several bacteria called superbugs that are resistant to multiple antibiotics which
can be life threatening specially for critically ill and hospitalized patients. This article …

[HTML][HTML] Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli

L Scudeller, E Righi, M Chiamenti, D Bragantini… - International journal of …, 2021 - Elsevier
Background: The superiority of combination therapy for carbapenem-resistant Gram-
negative bacilli (CR-GNB) remains controversial. In vitro models may predict the efficacy of …

In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing bla KPC or bla NDM

J Kuai, Y Zhang, B Lu, H Chen, Y Zhang… - Infection and Drug …, 2023 - Taylor & Francis
Background It is often challenging to select appropriate combination therapies to treat
infections caused by carbapenem-resistant Enterobacterales (CRE) with high-level …

[HTML][HTML] Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro

L Yu, J Zhang, Y Fu, Y Zhao, Y Wang, J Zhao… - Frontiers in Cellular …, 2019 - frontiersin.org
The purpose of this study was to investigate the synergistic and bactericidal effects of
combinations of colistin with meropenem or amikacin in vitro and provide laboratory data …

Are antimicrobial peptide dendrimers an escape from ESKAPE?

Y Kawano, O Jordan, T Hanawa, G Borchard… - Advances in wound …, 2020 - liebertpub.com
Significance: The crisis of antimicrobial resistance (AMR) increases dramatically despite all
efforts to use available antibiotics or last resort antimicrobial agents. The spread of the AMR …

[HTML][HTML] Assessment of in-vitro synergy of fosfomycin with meropenem, amikacin and tigecycline in whole genome sequenced extended and pan drug resistant …

M Al-Quraini, M Rizvi, Z Al-Jabri, H Sami… - Antibiotics, 2022 - mdpi.com
Fosfomycin has emerged as a very useful antimicrobial in management of extremely drug
resistant (XDR) and pan drug resistant (PDR) Klebsiella pneumoniae. In this study, we …

[HTML][HTML] A new approach to overcoming antibiotic-resistant bacteria: traditional chinese medicine therapy based on the gut microbiota

P Xue, R Sang, N Li, S Du, X Kong, M Tai… - Frontiers in cellular …, 2023 - frontiersin.org
With the irrational use of antibiotics and the increasing abuse of oral antibiotics, the drug
resistance of gastrointestinal pathogens has become a prominent problem in clinical …

Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Test for Enterobacterales-Containing Blood Cultures in China

Y Shan, B Hu, W Guo, B Wang, C Zhou… - Journal of Clinical …, 2022 - Am Soc Microbiol
Bloodstream infection (BSI) is defined by the presence of microbes in the bloodstream and
has high mortality. Early antimicrobial therapy is key to treating BSI patients. Because of …

Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro

J Zhang, L Yu, Y Fu, Y Zhao, Y Wang… - Annals of Palliative …, 2019 - apm.amegroups.org
Background: To investigate the activity of 5 antibiotic monotherapies, including colistin
(COL), meropenem (MEM), amikacin (AMK), levofloxacin (LEV), and tigecycline (TGC) …